Science Applications International Corporation

▲ Bull Case

• ◆NMCI recompete won outright for a 10-year term, eliminating the persistent ~20-30% valuation discount. Multiple re-rates to 14x EV/EBITDA (CACI peer level) implying ~$200-$235 stock price — +110-125% over five years.
• ◆Buyback compounding accelerates at depressed prices — at $105, every $200M of buyback reduces shares ~4.5%. Sustained 5 years eliminates ~22% of share count; combined with 5-7% adj. EBITDA growth, mechanical EPS CAGR exceeds 10% even without margin expansion.
• ◆Townes-Whitley's digital pivot delivers 2-3 large AI/modernization contracts at fixed-price outcome-based structures, demonstrating 12-15% incremental margins. Market re-rates SAIC from services to solutions multiple, closing the gap to BAH by half.

▼ Bear Case

• ◆NMCI lost to Leidos or GDIT on recompete — ~$1.1B revenue rolls off over 2 years; adj. EBITDA falls 20-25% as fixed costs stranded; buyback program pauses; stock declines to $75-$90 (-15-30% downside).
• ◆DOGE expansion to DoD efficiency programs cuts an additional 2-3 SAIC contracts (Army logistics, civilian IT); combined with NMCI uncertainty, FY2028 revenue declines another 4-6%; FCF falls below $400M and dividend comes under pressure.
• ◆FY2028 debt refinancing at 7.5%+ rates adds $30M+ annual interest expense post-FY2029; combined with weaker FCF, total capital return falls below $250M/yr; credit rating downgrade pressure builds toward junk territory.

“The Street debates three core issues: (1) NMCI recompete probability and timing — bull-side analysts underwrite 70-80% retention probability based on incumbency; bear-side argue 40-50% given Navy's interest in market-testing after 20+ years of single-source extensions. (2) DOGE persistence — bulls argue FY2027 was a one-time shock; bears argue DoD efficiency is a multi-year theme and FY2027 guidance is just the first downward revision. (3) Margin expansion credibility — management's 9%+ adj. EBITDA target by FY2028 has been deferred; unclear if SAIC can escape the ~7.8-8.0% structural ceiling without major mix shift. Market weighted toward bear interpretation on all three, evidenced by 12x EV/EBITDA vs. CACI's 14.7x.”

• ◆NMCI/NMCIe contract decision (RFP issuance or award) within 12-36 months — very high valuation impact (±20-30%)
• ◆DOGE clarity on FY2028 budget allocation within 6-12 months — medium impact (±5-10%)
• ◆Book-to-bill recovery sustained above 1.0x TTM within 3-9 months — signals pipeline health and confidence

• ◆NMCI Recompete Loss — 25-30% probability, very high severity, 12-36 month horizon; ~$1.1B revenue impact and 20-25% EBITDA decline
• ◆DOGE expansion to DoD IT programs — 25% probability, medium-high severity, 0-24 month horizon; 2-3 additional contracts at risk
• ◆FY2028 debt refinancing at elevated rates (7.5%+) — 70% probability, medium severity, 24 month horizon; $30M+ annual EPS headwind